SNHG16 as the miRNA let‐7b‐5p sponge facilitates the G2/M and epithelial‐mesenchymal transition by regulating CDC25B and HMGA2 expression in hepatocellular carcinoma
Authors:
- 7 November 2019
- journal article
- research article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 121 (3) , 2543-2558
Abstract
Long noncoding RNAs (lncRNAs) play crucial roles in hepatocellular carcinoma (HCC). However, the underlying molecular mechanisms of small nucleolar RNA host gene 16 (SNHG16) for regulating the cell cycle and epithelial to mesenchymal transition (EMT) remain elusive. In this study, SNHG16 expression profiles of HCC tissues or cell lines were compared with those of normal tissues or hepatocyte cell line. The effect of SNHG16 knockdown in HCC cell lines was investigated by using in vitro loss‐of‐function experiments and in vivo nude mouse experiments. The potential molecular regulatory mechanism of SNHG16 in HCC progression was investigated by using mechanistic experiments and rescue assays. The results revealed that SNHG16 was highly expressed in HCC tissues and cell lines, which predicted poor prognosis of HCC patients. On one hand, the downregulation of SNHG16 induced G2/M cell cycle arrest, inducing cell apoptosis and suppression of cell proliferation. On the other hand, it inhibited cell metastasis and EMT progression demonstrated by in vitro loss‐of‐function cell experiments. Besides, knockdown of SNHG16 increased the sensitivity of HCC cells to cisplatin. For the detailed mechanism, SNHG16 was demonstrated to act as a let‐7b‐5p sponge in HCC. SNHG16 facilitated the G2/M cell cycle transition by directly acting on the let‐7b‐5p/CDC25B/CDK1 axis, and promoted cell metastasis and EMT progression by regulating the let‐7b‐5p/HMGA2 axis in HCC. In addition, the mechanism of SNHG16 for regulating HCC cell proliferation and metastasis was further confirmed in vivo by mouse experiments. Furthermore, these results can provide new insights into HCC treatment and its molecular pathogenesis, which may enlighten the further research of the molecular pathogenesis of HCC.Keywords
Funding Information
- National Natural Science Foundation of China (31671371)
This publication has 46 references indexed in Scilit:
- Cdc25 Phosphatases Are Required for Timely Assembly of CDK1-Cyclin B at the G2/M TransitionJournal of Biological Chemistry, 2010
- Cell cycle, CDKs and cancer: a changing paradigmNature Reviews Cancer, 2009
- Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironmentCancer Cell, 2006
- Hepatocellular Carcinoma: The Need for ProgressJournal of Clinical Oncology, 2005
- Cellular processing of platinum anticancer drugsNature Reviews Drug Discovery, 2005
- Molecular Mechanisms of Mammalian DNA Repair and the DNA Damage CheckpointsAnnual Review of Biochemistry, 2004
- Cell-cycle dysregulation and anticancer therapyTrends in Pharmacological Sciences, 2003
- Cdc2 tyrosine phosphorylation is required for the DNA damage checkpoint in fission yeast.Genes & Development, 1997
- Principles of CDK regulationNature, 1995
- Analysis of Events Associated With Cell Cycle Arrest at G2 Phase and Cell Death Induced by CisplatinJNCI: Journal of the National Cancer Institute, 1990